Host: Matt Birnholz, MD

Guest: William Short, MD

Since the discovery of HIV more than 3 decades ago, there has been progress in the treatment of the disease. However, there remains a significant need to continue providing adults living with HIV and their physicians with treatment options. The last few years have seen the development of additional treatment options, including fixed-dose combination therapies. Dr. William Short, Associate Professor at Perelman School of Medicine at the University of Pennsylvania in Philadelphia, joins Dr. Matt Birnholz to discuss the considerations in treatment options for adults living with HIV-1, highlighting PREZCOBIX® (darunavir 800 mg/cobicistat 150 mg), one of the treatments in the space. Download and listen today. For more information on PREZCOBIX®, please visit www.PREZCOBIX.com/hcp. This promotional program is sponsored by Janssen Therapeutics, Division of Janssen Products, LP.